Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 7 of 620 for:    oximeter

Investigating a Wrist-sensor Oximeter to Screen for Sleep Apnoea.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04018547
Recruitment Status : Not yet recruiting
First Posted : July 12, 2019
Last Update Posted : July 12, 2019
Sponsor:
Collaborator:
The London Sleep Centre
Information provided by (Responsible Party):
Oxitone Medical Ltd.

Brief Summary:
The primary study objective is to investigate sensitivity and specificity of a wrist sensor pulse oximeter (the Oxitone Medical Oxitone 1000M device) to screen for obstructive sleep apnoea. This study will involve thirty participants attending a sleep centre suspected of suffering from obstructive sleep apnoea (case finding screening). The secondary objective is to assess patient convenience with the screening procedure.

Condition or disease Intervention/treatment
Obstructive Sleep Apnea Device: Patient wears a wrist sensor oximeter device for one to two nights.

Detailed Description:
This is an observational study to assess the sensitivity and specificity of a wrist sensor pulse oximeter (Oxitone Medical Oxitone 1000M) to identify obstructive sleep apnoea cases in patients referred to the London Sleep Centre (case finding screening, or case only study). The wrist sensor pulse oximeter streams data (pulse rate, heart rate variability (HRV), blood oxygen saturation levels (SPO2), actigraphy data and skin temperature data) to a software application using bluetooth connectivity to be stored in a securely encrypted database cloud for analysis. The investigators at the sleep centre will be masked when analysing the data from the wrist sensor pulse oximeter when deciding on diagnosis of obstructive sleep apnoea. Data from the wrist sensor oximeter device will be statistically compared with the data from a conventional PPG fingertip oximeter and Peripheral Arterial Tonometry device currently in use. The study outcome will be whether the wrist sensor pulse oximeter device could be used in patients to screen reliably for obstructive sleep apnoea. The study also will include patient feedback on convenience of the screening procedure. The study will not affect routine patient medical management and care for patients assessed at the sleep centre.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Investigating the Use of a Wrist-sensor Pulse Oximeter to Screen for Obstructive Sleep Apnoea.
Estimated Study Start Date : September 17, 2019
Estimated Primary Completion Date : December 17, 2019
Estimated Study Completion Date : December 17, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sleep Apnea


Intervention Details:
  • Device: Patient wears a wrist sensor oximeter device for one to two nights.
    Patients will be asked to complete a study questionnaires of STOPBANG, SCI-8 (Sleep Condition Indicator-8 questionnaire for insomnia), Epworth questionnaires and medical history. The clinician will record blood pressure, pulse rate and regularity, body mass index and neck circumference. Subjects will be required to wear the wrist sensor pulse oximeter for 1-2 nights. The Oxitone 1000M device measures pulse rate, blood oxygen saturation and movement. The oxygen desaturation events from the wrist sensor device will be statistically compared with the diagnosis assessed using the conventional PPG oximetry, Peripheral Arterial Tonometry and clinical assessment. (clinicians will be masked when analysing the data from the wrist sensor pulse device).


Primary Outcome Measures :
  1. obstructive sleep apnoea screening [ Time Frame: Three months ]
    Sensitivity and specificity of the wrist sensor oximeter to screen for obstructive sleep apnoea by (A) comparing the SPO2 3% and 4 % dip rates of the conventional fingertip photoplethysmography(PPG) oximeter to the 3% and 4% dip rates of the wrist sensor pulse oximeter and (B) comparing the final diagnosis of obstructive sleep apnoea (OSA) by a sleep specialist (based on PPG fingertip oximetry and peripheral arterial tonometry), with SPO2 and heart rate variability data from the wrist sensor pulse oximeter. The sleep specialist will be masked from the data of the wrist sensor pulse oximeter. An ROC (receiver operating characteristic) curve will be used for (B).


Secondary Outcome Measures :
  1. Patient comfort and compliance [ Time Frame: Three months ]
    To assess patient comfort wearing the wrist sensor pulse oximetry device by administering a questionnaire with responses on a Likert scale to question "the wrist sensor pulse oximeter was comfortable to sleep with"



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 68 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Thirty consecutive patients referred to the sleep Centre for screening for sleep apnoea that consented to involvement in the study.
Criteria

Inclusion Criteria:

  • Thirty consecutive patients referred to the sleep Centre for screening for sleep apnoea that consented to involvement in the study.

Exclusion Criteria:

  • Patients who are unable to give written informed consent.
  • anaemia or dysfunctional hemoglobin
  • upper limb complaints affecting the ability to wear the watch like wrist sensor device such as tenderness, deformity or swelling, skin complaints such as ulceration, swelling or skin breaks
  • impairment in circulation in the left upper limb (active Raynauds or other vascular impairment)
  • neurological conditions such as tremor or convulsions
  • Medical conditions likely to affect the blood oxygen such as chronic obstructive pulmonary disease (COPD) and chronic asthma
  • Neurological conditions likely to affect breathing such as stroke
  • Conditions likely to affect autonomic nervous system such as diabetes mellitus

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04018547


Contacts
Layout table for location contacts
Contact: Leon Eisen, PhD +97278346731 Leon.eisen@oxitone.com
Contact: Werner Stipp, MBCHB MFOM DIH +447597558426 Werner.stipp@oxitone.com

Locations
Layout table for location information
United Kingdom
London Sleep Centre Not yet recruiting
London, United Kingdom, W1G6BF
Contact: Irshaad Ebrahim, MBCHB FRCPsych    +442077250523    Info@londonsleepcentre.com   
Principal Investigator: Werner Stipp, MBCHB MFOM DIH         
Sponsors and Collaborators
Oxitone Medical Ltd.
The London Sleep Centre

Study Data/Documents: Individual Participant Data Set  This link exits the ClinicalTrials.gov site
De-identified data for primary and secondary outcome measures

Layout table for additonal information
Responsible Party: Oxitone Medical Ltd.
ClinicalTrials.gov Identifier: NCT04018547     History of Changes
Other Study ID Numbers: 265604
First Posted: July 12, 2019    Key Record Dates
Last Update Posted: July 12, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description:

All IPD that underlie results in a publication will be shared with other researchers.

Personal identifiable data will not be shared with other researchers.

Supporting Materials: Study Protocol
Clinical Study Report (CSR)
Time Frame: Three months
Access Criteria: Contact Oxitone for access
URL: http://www.oxitone.com

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Oxitone Medical Ltd.:
Screening, patient convenience
Additional relevant MeSH terms:
Layout table for MeSH terms
Apnea
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases